SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 42 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $76 | +1.3% | 76,000 | 0.0% | 0.00% | – |
Q4 2022 | $75 | -99.9% | 76,000 | 0.0% | 0.00% | – |
Q3 2022 | $74,000 | -64.6% | 76,000 | -64.8% | 0.00% | – |
Q2 2022 | $209,000 | +6866.7% | 216,000 | +7100.0% | 0.00% | – |
Q2 2021 | $3,000 | -99.5% | 3,000 | -99.5% | 0.00% | – |
Q4 2020 | $627,000 | -36.0% | 655,000 | -45.9% | 0.00% | -100.0% |
Q1 2020 | $979,000 | +30.0% | 1,210,000 | +46.3% | 0.00% | – |
Q4 2019 | $753,000 | +37.2% | 827,000 | +40.2% | 0.00% | – |
Q3 2019 | $549,000 | +200.0% | 590,000 | +205.7% | 0.00% | – |
Q2 2019 | $183,000 | – | 193,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 46,902,000 | $45,737,000 | 4.40% |
INCOME RESEARCH & MANAGEMENT | 7,500,000 | $7,280,000 | 3.12% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 96,994,000 | $94,477,000 | 2.13% |
PIPER SANDLER & CO. | 2,200,000 | $2,112,000 | 1.92% |
DeepCurrents Investment Group LLC | 41,092,000 | $39,934,000 | 1.59% |
Radcliffe Capital Management, L.P. | 69,010,000 | $66,983,000 | 1.54% |
Sonora Investment Management Group, LLC | 9,635,000 | $9,389,000 | 0.89% |
Penn Mutual Asset Management | 675,000 | $656,000 | 0.88% |
OAKTREE CAPITAL MANAGEMENT LP | 24,447,000 | $23,851,000 | 0.28% |
WOLVERINE ASSET MANAGEMENT LLC | 8,681,000 | $8,429,000 | 0.08% |